Dendreon Corporation Completes Acquisition Of Corvas International

Dendreon Corporation has announced that it has completed its acquisition of Corvas International. The acquisition provides Dendreon with an enhanced product pipeline and the financial position to discover, develop and commercialize innovative therapeutic products in oncology. “This is a very exciting time for Dendreon, our stockholders and the many cancer patients who could potentially benefit Read more about Dendreon Corporation Completes Acquisition Of Corvas International[…]

Genentech

Luminex Announces Letter Of Intent To Sell RBM

Luminex Corporation has announced it has entered into a nonbinding letter of intent to divest its Rules-Based Medicine research and development project (“RBM”) to a newly formed company to be headed by Dr. Mark B. Chandler, Luminex’s current Chairman, President and Chief Executive Officer. RBM uses the Luminex xMAP(TM) technology to analyze a large number Read more about Luminex Announces Letter Of Intent To Sell RBM[…]